The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

FDA hands Chi­nese drug man­u­fac­tur­er a Form 483 not­ing em­ploy­ees de­stroyed doc­u­ments 

11 months ago
China
FDA+

AI is un­like­ly to take off among CD­MOs at the same scale as bio­phar­ma com­pa­nies, in­sid­ers say

11 months ago
AI

Rayze­Bio warned of po­ten­tial iso­tope sup­ply is­sues be­fore BMS deal

11 months ago
R&D

Ex­clu­sive: Iso­tope short­age forces pause of Bris­tol My­ers Phase 3 ra­dio­phar­ma­ceu­ti­cal tri­al

11 months ago
R&D
Pharma

Adap­ti­m­mune taps Gala­pa­gos to de­cen­tral­ize man­u­fac­tur­ing of sol­id tu­mor T cell ther­a­py

11 months ago
Deals
Cell/Gene Tx

FDA to be­gin re­struc­tur­ing its in­spec­tion of­fice in Oc­to­ber

11 months ago
FDA+

Al­mac’s 2023 rev­enue bump; France to in­vest in eas­ing green­house gas im­pact

11 months ago

Ori Biotech, Cy­ti­va sep­a­rate­ly un­veil tech to ac­cel­er­ate cell ther­a­py pro­duc­tion

11 months ago
Cell/Gene Tx

GLP-1 pre­scrip­tions reach all-time high as Lil­ly and No­vo scram­ble to keep pace with de­mand

11 months ago
Pharma

Lil­ly bud­gets ad­di­tion­al $5.3B for tirzepatide API fac­to­ry in In­di­ana

11 months ago

Chi­nese CD­MO takes over Pfiz­er’s UK fa­cil­i­ty; Serum In­sti­tute ships malar­ia vac­cine to Africa

11 months ago

Mer­ck KGaA makes $600M bet to boost man­u­fac­tur­ing for vi­ral vec­tors

11 months ago
Deals
Cell/Gene Tx

AGC Bi­o­log­ics, Bio­Con­nec­tion forge part­ner­ship to be an al­ter­na­tive to WuXi

11 months ago
China

Evotec ends gene ther­a­py busi­ness, shuts down fa­cil­i­ty in Aus­tria

11 months ago
Pharma
Cell/Gene Tx

As­traZeneca ear­marks $1.5B for end-to-end ADC fac­to­ry in Sin­ga­pore

11 months ago

WuXi Bi­o­log­ics paus­es Mass­a­chu­setts build; No­vo Hold­ings nabs ma­jor­i­ty stake in phar­ma tools firm  

12 months ago

Aim­ing to de­cen­tral­ize CAR-T man­u­fac­tur­ing, Gala­pa­gos part­ners with largest US blood sup­ply net­work

12 months ago
Cell/Gene Tx

Mer­ck KGaA stays pos­i­tive on CD­MO arm’s fu­ture de­spite first-quar­ter slump

12 months ago

WuXi AppTec trims 's­mall per­cent­age' of work­ers at US site as mar­ket shifts

12 months ago
People

New­Vale un­veils $167M fund to back phar­ma ser­vice providers and 'old ideas that are work­ing'

Last year
Financing
Outsourcing

Up­dat­ed: France draws €2B+ re­search, man­u­fac­tur­ing in­vest­ment from Sanofi, Pfiz­er, As­traZeneca, GSK

Last year
Financing

AGC Bi­o­log­ics to cut close to 4% of staffers 'to ad­just busi­ness pri­or­i­ties'

Last year
People

Charles Riv­er touts first-quar­ter man­u­fac­tur­ing rev­enue, says Chi­na bill is ‘net pos­i­tive’

Last year
China

Nu­cle­us Ra­dio­Phar­ma makes Art­bio’s ra­dio­phar­ma as­sets; Mi­naris man­u­fac­tures blue­bird’s Lyf­ge­nia 

Last year
First page Previous page 11121314151617 Next page Last page
A service from the Financial Times